StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > SO THIS IS STILL A GO. [ FROM MDA ]

<< Previous

Bullboard Posts

Next >>

Comment by frewil11on Apr 05, 2021 10:11am

124 Views

Post# 32936659

RE:RE:SO THIS IS STILL A GO. [ FROM MDA ]

Ya I just dont know why the company has not given any updates on these initiatives at all , are they still in talks and pursuing these avenues or whats going on , I like the clinic partnership but they need more , I can not see all of these talks that have been going on for a couple of years now all not leading to contracts , does anybody having anything on this issue.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing